Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer
We have developed a Discussion Prioritization Tool (DPT) for older adults consider adjuvant chemotherapy that utilizes Conjoint Analysis (CA) methodology and the objective of the current study is to assess usability of this DPT in our target population, older adults with breast cancer and to adapt the tool to optimize usability for our target population.
|Condition or Disease||Intervention/Treatment||Phase|
Given the complexity of adjuvant chemotherapy decision making for older adults with breast cancer, enhancing support and promoting treatment discussions in the context of patient's goals and preferences is an important need. With this need in mind, our group has completed interviews with patients with cancer patients who are considering adjuvant therapy. As a result of these interviews, our group has developed a common list of attributes (variables found to be important in decision making) that were used to create the Discussion Prioritization Tool (DPT) using Conjoint Analysis (CA) methodology. CA which is a method that can assess the relative importance that patients place on different aspects of care by asking patients to make a series of trade-offs between competing options. The purpose of this study is to assess the usability of a Discussion Prioritization Tool, administered through a tablet, laptop, or computer, for its ability to aid in treatment decision-making. We would like to gather feedback from individuals to improve and adapt the communication tool.
Arms and Interventions
Electronic completion of Geriatric Assessment and Conjoint Analysis with result output.
Usability of the Discussion Prioritization Tool (DPT) by completing Geriatric Assessment and Conjoint Analysis
Primary Outcome Measures
- Functional Assessment of the Discussion Prioritization Tool (DPT) [2 Months]
System Usability Scale (SUS) (score on 10-item scale, total score ranging 0-100; higher score corresponds to greater usability). We will deem the tool usable if our mean SUS score among the 10 patients enrolled is >68.
Diagnosis of stage I-III BC
Being considered for adjuvant chemotherapy
Able to speak and read English
Able to participate in study procedures.
Lacking medical decision-making capacity as determined by their oncologist
Evidence of metastatic disease
Contacts and Locations
|1||University of Rochester||Rochester||New York||United States||14642|
Sponsors and Collaborators
- University of Rochester
- Principal Investigator: Allison Magnuson, DO, Univ. of Rochester Wilmot Cancer Center
Study Documents (Full-Text)None provided.